Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?
NKT-cell-based
Natural killer T (NKT) cells constitute a unique subset of innate-like T lymphocytes which differ from conventional T cells by recognizing lipid antigens presented by the non-polymorphic major histocompatibility complex (MHC) I-like molecule CD1d. 
CD1d